Our Scientific Advisory Boards are composed of preeminent experts across medical, surgical, and radiation oncology, interventional radiology, and immunology who provide counsel and real world insight as we advance our treatments.
Scientific Advisory Board – Oncology
Steven Katz, MD, FACS
TriSalus Life Sciences Chief Medical Officer, Chairman SAB
Director, Surgical Oncology Fellowship and Office of Therapeutic Development, and leads Cellular Immunotherapy and Gene Therapy Facility at Roger Williams Medical Center, RI
Christopher Crane, MD
Vice Chair, Dept of Radiation Oncology, Memorial Sloan Kettering Cancer Center
Member of NCI-Gastrointestinal Steering Committee
NRG Oncology Group; ASTRO, ASCO Pancreatic Clinical Practice Guidelines
Emeritus Scientific and Medical Advisory Board of PANCAN
Philip Philip, MD
Professor of Oncology, Pharmacology and Medicine, the Kathryn Cramer Endowed Chair in Cancer Research, Vice President of Medical Affairs, Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine
Chair pancreatic cancer committee, Southwest Oncology Group (SWOG)
Scientific and Medical Advisory Board for PANCAN
Vincent Picozzi, MD
Director, Pancreatic Center for Excellence, Virginia Mason Medical Center
BOD, Washington State Medical Oncology Society
Chair of the Precision Promise Clinical Trial Consortium
Gabriela Plesa, MD, PhD
Director of Translational Science Operations, Deputy Director Cell and Vaccine Production Facility, University of Pennsylvania
Scientific Advisory Board – Interventional Radiology
Terence Gade, MD, PhD
Assistant Professor of Radiology, Penn Presbyterian Medical Center. Attending, Hospital of the University of Pennsylvania. Assistant Investigator, Abramson Cancer Research Institute.
Co-founded the Penn Image-Guided Interventions (PIGI) Laboratory. The interests of the laboratory focus on translational research for the development of novel imaging approaches and advanced therapeutics.
Ripal Gandhi, MD
Clinical Professor at the University of South Florida School of Medicine and FIU Herbert Wertheim College of Medicine. Attending, Miami Cardiac & Vascular Institute and Miami Cancer Institute.
Co-authored textbook, Interventional Oncology. Program Director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).
Ahmed Kamel Abdel Aal, MD, PhD, FSIR
Professor of Interventional Radiology and Chief, Section of Interventional Radiology at University of Texas Health Science Center at Houston (UTHealth) Department of Diagnostic and Interventional Imaging. Clinical interests are Interventional Oncology, Dialysis interventions and Spine interventions.
Alexander Y. Kim, MD
Associate Professor of Radiology at Georgetown University Medical Center where he serves as the Chief of the Division of Interventional Radiology.
Interest in oncology to develop methods to augment outcomes from liver-directed therapies and identifying methods to augment response to immunotherapy with local therapy. Currently serves as a PI in a number of investigator initiated and multi-center trials.
Sirish Kishore, MD
Assistant Professor of Radiology at Weill Cornell Medical College, New York City. Attending, Memorial Sloan Kettering Cancer Center.
Interests in catheter-based and percutaneous techniques to improve the therapeutic index of cellular and IOs. Collaborates with members of the MSKCC Cellular Therapeutics Center and Immunotherapy Committee.
Daniel Sze, MD, PhD
Professor of Interventional Radiology at Stanford University Medical Center.
Authored over 400 papers, books, and abstracts, and has been an investigator in over 60 clinical trials. Serves as an advisory board member or consultant to a multitude of device and pharmaceutical companies, including start-ups in his neighborhood of Silicon Valley.